Skip to main content

Dec 2026–Jan 2027

CFP closes 4 Dec

Global Summit on Immunotherapy & Cancer Breakthroughs

GSICB 2026

Global Summit on Immunotherapy & Cancer Breakthroughs is a 2-day event in Bordeaux, France on 31 Dec – 1 Jan 2027, organized by World Research Association for Education and Science. Abstracts are due by 4 December 2026. Its call for papers covers Advanced Cancer Immunotherapy, • Next Generation Immunotherapy and • Precision Cancer Immunotherapy, among other areas. World Research Association for Education and Science has 389 other upcoming conferences listed here.

Call for papers closing soon

Important dates

  1. Abstract / full paper deadline

    In 18 days

  2. Conference

    Bordeaux, France

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

Global Summit on Immunotherapy & Cancer Breakthroughs GSICB, organized by World Research Association for Education and Science, is a leading international conference that connects researchers, engineers, healthcare professionals, academicians, scientists, industry experts, and professionals from around the world. The conference provides a global platform to share groundbreaking research, discuss emerging developments, showcase innovative ideas, and build meaningful professional collaborations. By bringing together diverse academic and professional communities, Global Summit on Immunotherapy & Cancer Breakthroughs GSICB aims to promote knowledge exchange, interdisciplinary collaboration, innovation, and the advancement of research on a global scale.

Topics and scope

  • Advanced Cancer Immunotherapy
  • • Next Generation Immunotherapy
  • • Precision Cancer Immunotherapy
  • • Immune Checkpoint Inhibitors
  • • PD1 PDL1 Targeting
  • • CTLA4 Targeted Therapy
  • • Nextgen Checkpoint Strategies
  • • CAR T Cell Therapy
  • • Next Generation CAR T
  • • In Vivo CAR T
  • • CAR NK Cell Therapy
  • • Engineered T Cell Therapies
  • • TCR T Cell Therapy
  • • Adoptive Cell Therapies
  • • Tumor Infiltrating Lymphocytes
  • • Bispecific Antibody Therapies
  • • Multispecific Immune Engagers
  • • T Cell Engager Platforms
  • • Cancer Vaccine Innovations
  • • Personalized Cancer Vaccines
  • • Neoantigen Vaccine Development
  • • mRNA Cancer Vaccines
  • • In Situ Cancer Vaccines
  • • Oncolytic Virus Immunotherapy
  • • Cancer Immunotherapy Combinations
  • • Immunotherapy Drug Combinations
  • • Targeted Immunotherapy Strategies
  • • Tumor Microenvironment Modulation
  • • Immune Suppressive Microenvironment
  • • Tumor Immune Escape
  • • Immunotherapy Resistance Mechanisms
  • • Overcoming Immunotherapy Resistance
  • • Biomarkers For Immunotherapy
  • • Predictive Immune Biomarkers
  • • Precision Immuno Oncology
  • • AI Driven Immunotherapy
  • • Computational Cancer Immunology
  • • Genomic Immunotherapy Biomarkers
  • • Personalized Immune Treatments
  • • Immunotherapy For Solid Tumors
  • • Immunotherapy For Blood Cancers
  • • Lung Cancer Immunotherapy
  • • Breast Cancer Immunotherapy
  • • Melanoma Immunotherapy Advances
  • • Colorectal Cancer Immunotherapy
  • • Brain Cancer Immunotherapy
  • • Immunotherapy Toxicity Management
  • • Cytokine Release Syndrome
  • • Immune Related Adverse Events
  • • Clinical Immunotherapy Translation

Call for papers

Abstracts are due by 4 December 2026. Submission details are on the official website.

Where this information comes from

Source
Submitted by the organizer
Listed on
19 October 2026
Verification
Reviewed by an editor before publishing
Reference
FCA2894173

Questions about GSICB 2026

When and where is GSICB 2026?

31 Dec – 1 Jan 2027 in Bordeaux, France.

Can I attend online?

This listing does not confirm an online option. Check the official website.

What is the submission deadline?

Abstracts are due by 4 December 2026.

How do I register?

Registration and fees are handled by the organizer on the official website.

Visit Website